CLINICAL ROLE -
Opinion
Video
Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.
Study: In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults
Key Considerations for the Effective Utilization of RSV Vaccines
RSV Vaccine Displays Effectiveness Against RSV-Associated Hospitalizations
Researchers Highlight Need for Increased RSV Vaccination
Public Concern of RSV Infection Has Decreased as Flu and COVID-19 Remain a Worry
FDA Approves Abrysvo to Treat Adults 18 to 59 Years of Age at Increased Risk for RSV